EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The gut microbiota as an early predictor of COVID-19 severity

Marco Fabbrini iD, Federica D'Amico iD, Bernardina T F van der Gun, Monica Barone iD, Gabriele Conti iD, Sara Roggiani iD, Karin I Wold, María F Vincenti-Gonzalez, Gerolf C de Boer iD, Alida C M Veloo iD, Margriet van der Meer, Elda Righi iD und 10 weitere

mSphere · 2024

DOI: 10.1128/msphere.00181-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mSphere, 2024. Verfasst von Marco Fabbrini und 21 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Microbiome Science and Biotechnology, Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy. Hauptthemen laut MEDLINE: COVID-19, Gastrointestinal Microbiome, Severity of Illness Index, SARS-CoV-2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EC | Horizon 2020 Framework Programme, ZonMw, Fondazione Cassa di Risparmio di Verona Vicenza Belluno e Ancona.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Several studies reported alterations of the human gut microbiota (GM) during COVID-19. To evaluate the potential role of the GM as an early predictor of COVID-19 at disease onset, we analyzed gut microbial samples of 315 COVID-19 patients that differed in disease severity. We observed significant variations in microbial diversity and composition associated with increasing disease severity, as the reduction of short-chain fatty acid producers such as Faecalibacterium and Ruminococcus , and the growth of pathobionts as Anaerococcus and Campylobacter . Notably, we developed a multi-class machine-learning classifier, specifically a convolutional neural network, which achieved an 81.5% accuracy rate in predicting COVID-19 severity based on GM composition at disease onset. This achievement highlights its potential as a valuable early biomarker during the first week of infection. These findings offer promising insights into the intricate relationship between GM and COVID-19, providing a potential tool for optimizing patient triage and streamlining healthcare during the pandemic. IMPORTANCE Efficient patient triage for COVID-19 is vital to manage healthcare resources effectively. This study underscores the potential of gut microbiota (GM) composition as an early biomarker for COVID-19 severity. By analyzing GM samples from 315 patients, significant correlations between microbial diversity and disease severity were observed. Notably, a convolutional neural network classifier was developed, achieving an 81.5% accuracy in predicting disease severity based on GM composition at disease onset. These findings suggest that GM profiling could enhance early triage processes, offering a novel approach to optimizing patient management during the pandemic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Gastrointestinal MicrobiomeSeverity of Illness IndexSARS-CoV-2HumansFemaleMaleMachine LearningMiddle AgedAdultFecesBiomarkersAgedBacteria

Stichwörter der Autor:innen

COVID-19 severitygut microbiotamachine learning

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Unit of Microbiome Science and Biotechnology, Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
  • Human Microbiomics Unit, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Department of Medical Microbiology and Infection Prevention, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Spatial Epidemiology Lab (SpELL), Université Libre de Bruxelles (ULB), Brussels, Belgium.
  • Department of Diagnostics and Public Health, Infectious Diseases Department, University of Verona, Verona, Italy.

ORCID-Profile: Marco Fabbrini, Federica D'Amico, Monica Barone, Gabriele Conti, Sara Roggiani, Gerolf C de Boer, Alida C M Veloo, Elda Righi, Elisa Gentilotti, Anna Górska, Massimo Mirandola, Maria Mongardi, Evelina Tacconelli, Silvia Turroni, Patrizia Brigidi, Adriana Tami

Förderung

  • EC | Horizon 2020 Framework Programme
  • ZonMw
  • Fondazione Cassa di Risparmio di Verona Vicenza Belluno e Ancona

Zitieren

APA

Fabbrini, M., D'Amico, F., van der Gun, B. T. F., Barone, M., Conti, G., Roggiani, S., Wold, K. I., Vincenti-Gonzalez, M. F., de Boer, G. C., Veloo, A. C. M., van der Meer, M., Righi, E., Gentilotti, E., Górska, A., Mazzaferri, F., Lambertenghi, L., Mirandola, M., Mongardi, M., Tacconelli, E., …, & Tami, A. (2024). The gut microbiota as an early predictor of COVID-19 severity. mSphere. https://doi.org/10.1128/msphere.00181-24

Vancouver

Fabbrini M, D'Amico F, van der Gun BTF, Barone M, Conti G, Roggiani S, et al. The gut microbiota as an early predictor of COVID-19 severity. mSphere. 2024. doi:10.1128/msphere.00181-24

BibTeX
@article{Fabbrini2024,
  author = {Fabbrini, Marco and D'Amico, Federica and van der Gun, Bernardina T F and Barone, Monica and Conti, Gabriele and Roggiani, Sara and Wold, Karin I and Vincenti-Gonzalez, María F and de Boer, Gerolf C and Veloo, Alida C M and van der Meer, Margriet and Righi, Elda and Gentilotti, Elisa and Górska, Anna and Mazzaferri, Fulvia and Lambertenghi, Lorenza and Mirandola, Massimo and Mongardi, Maria and Tacconelli, Evelina and Turroni, Silvia and Brigidi, Patrizia and Tami, Adriana},
  title = {The gut microbiota as an early predictor of COVID-19 severity},
  journal = {mSphere},
  year = {2024},
  doi = {10.1128/msphere.00181-24}
}
Kostenlos starten →